Inventor · disambiguated record
Qingfeng Xia
Also filed as: XIA QINGFENG
0 granted patents·6 pending applications·0 citations·filing 2021–2024
Files withSHANGHAI REINOVAX BIOLOGICS CO LTD3WUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY2HUMANWELL HEATHCARE GROUP CO LTD1
Top patents by PatentIndex Score
6 records- 0157US2025290058A1Method for purifying tetanus toxin or variants thereofSHANGHAI REINOVAX BIOLOGICS CO LTD·Filed 2024·Application pending·0 cites
- 0255US2025352631A1Polyvalent pneumococcal polysaccharide conjugate vaccine component and application thereofSHANGHAI REINOVAX BIOLOGICS CO LTD·Filed 2023·Application pending·0 cites
- 0354US2025214986A1P2x3 inhibitor compound, salt thereof, polymorph thereof and use thereofHUMANWELL HEATHCARE GROUP CO LTD·Filed 2023·Application pending·0 cites
- 0452US2024368088A1Ep4 antagonist compound as well as salt, polymorph and use thereofWUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY·Filed 2022·Application pending·0 cites
- 0548US2023312582A1Salts Of Nitrogen-Containing Heterocyclic Compound, And Solid Forms Of Salts, Pharmaceutical Composition And Use ThereofWUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY·Filed 2021·Application pending·0 cites
- 0647US2023405104A1Proteoglycan conjugate and application thereofSHANGHAI REINOVAX BIOLOGICS CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qingfeng Xia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →